fenclonine has been researched along with Behavior Disorders in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Woert, MH | 1 |
| Ambani, LM | 1 |
| Levine, RJ | 1 |
| Wyatt, RJ | 1 |
2 trials available for fenclonine and Behavior Disorders
| Article | Year |
|---|---|
Clinical effects of para-chlorophenylalanine in Parkinson's disease.
Topics: Aged; Benztropine; Brain; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation S | 1972 |
The serotonin-catecholamine-dream bicycle: a clinical study.
Topics: 5-Hydroxytryptophan; Aged; Brain; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Dihydro | 1972 |